714 related articles for article (PubMed ID: 23597130)
1. Smell identification function as a severity and progression marker in Alzheimer's disease.
Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
[TBL] [Abstract][Full Text] [Related]
2. Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil.
Velayudhan L; Lovestone S
J Clin Psychopharmacol; 2009 Aug; 29(4):387-90. PubMed ID: 19593181
[TBL] [Abstract][Full Text] [Related]
3. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.
Devanand DP; Michaels-Marston KS; Liu X; Pelton GH; Padilla M; Marder K; Bell K; Stern Y; Mayeux R
Am J Psychiatry; 2000 Sep; 157(9):1399-405. PubMed ID: 10964854
[TBL] [Abstract][Full Text] [Related]
4. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
5. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type.
Gray AJ; Staples V; Murren K; Dhariwal A; Bentham P
Int J Geriatr Psychiatry; 2001 May; 16(5):513-7. PubMed ID: 11376468
[TBL] [Abstract][Full Text] [Related]
6. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease.
Suzuki Y; Yamamoto S; Umegaki H; Onishi J; Mogi N; Fujishiro H; Iguchi A
Int J Geriatr Psychiatry; 2004 Aug; 19(8):727-33. PubMed ID: 15290695
[TBL] [Abstract][Full Text] [Related]
7. Olfactory identification deficits at identification as ultra-high risk for psychosis are associated with poor functional outcome.
Lin A; Brewer WJ; Yung AR; Nelson B; Pantelis C; Wood SJ
Schizophr Res; 2015 Feb; 161(2-3):156-62. PubMed ID: 25476117
[TBL] [Abstract][Full Text] [Related]
8. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
Park SJ; Lee JE; Lee KS; Kim JS
Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
[TBL] [Abstract][Full Text] [Related]
9. Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease.
Kjelvik G; Sando SB; Aasly J; Engedal KA; White LR
Int J Geriatr Psychiatry; 2007 Oct; 22(10):1020-4. PubMed ID: 17299804
[TBL] [Abstract][Full Text] [Related]
10. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques.
Peters JM; Hummel T; Kratzsch T; Lötsch J; Skarke C; Frölich L
Am J Psychiatry; 2003 Nov; 160(11):1995-2002. PubMed ID: 14594747
[TBL] [Abstract][Full Text] [Related]
11. Pattern of Smell Identification Impairment in Alzheimer's Disease.
Velayudhan L; Gasper A; Pritchard M; Baillon S; Messer C; Proitsi P
J Alzheimers Dis; 2015; 46(2):381-7. PubMed ID: 25757648
[TBL] [Abstract][Full Text] [Related]
12. Olfactory ability in normal pressure hydrocephalus as compared to Alzheimer's disease and healthy controls.
Passler JS; Doty RL; Dolske MC; St Louis PG; Basignani C; Pepe JW; Bushnev S
J Neurol Sci; 2017 Jan; 372():217-219. PubMed ID: 28017216
[TBL] [Abstract][Full Text] [Related]
13. Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease.
Bahar-Fuchs A; Moss S; Rowe C; Savage G
Int Psychogeriatr; 2011 Sep; 23(7):1097-106. PubMed ID: 21251352
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
[TBL] [Abstract][Full Text] [Related]
15. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
[TBL] [Abstract][Full Text] [Related]
17. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
[TBL] [Abstract][Full Text] [Related]
18. Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment.
Fusetti M; Fioretti AB; Silvagni F; Simaskou M; Sucapane P; Necozione S; Eibenstein A
J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):175-81. PubMed ID: 20211105
[TBL] [Abstract][Full Text] [Related]
19. Olfaction in patients with mild cognitive impairment and Alzheimer's disease.
Djordjevic J; Jones-Gotman M; De Sousa K; Chertkow H
Neurobiol Aging; 2008 May; 29(5):693-706. PubMed ID: 17207898
[TBL] [Abstract][Full Text] [Related]
20. Assessing olfactory abilities with the University of Pennsylvania smell identification test: a Rasch scaling approach.
Lange R; Donathan CL; Hughes LF
J Alzheimers Dis; 2002 Apr; 4(2):77-91. PubMed ID: 12214131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
